Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/syndax-announces-participation-at-the-stifel-2024-virtual-targeted-oncology-forum-302113234.html
https://www.prnewswire.com/news-releases/syndax-presents-positive-pediatric-data-from-pivotal-augment-101-trial-of-revumenib-in-relapsedrefractory-kmt2ar-acute-leukemia-at-aspho-plenary-session-302109899.html
https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302107801.html
https://www.prnewswire.com/news-releases/syndax-announces-completion-of-enrollment-in-augment-101-pivotal-trial-cohort-of-patients-with-relapsedrefractory-mnpm1-acute-myeloid-leukemia-302101901.html
https://www.prnewswire.com/news-releases/syndax-announces-fda-priority-review-of-nda-for-revumenib-for-the-treatment-of-relapsedrefractory-kmt2ar-acute-leukemia-302100145.html
https://www.prnewswire.com/news-releases/syndax-announces-appointment-of-steven-closter-as-chief-commercial-officer-302091049.html
https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302077507.html
https://www.prnewswire.com/news-releases/syndax-pharmaceuticals-reports-fourth-quarter-and-full-year-2023-financial-results-and-provides-clinical-and-business-update-302073241.html
https://www.prnewswire.com/news-releases/syndax-announces-participation-at-two-upcoming-investor-conferences-302070276.html
https://www.prnewswire.com/news-releases/syndax-to-announce-fourth-quarter-and-year-end-2023-financial-results-and-host-conference-call-and-webcast-on-february-27-2024-302066595.html